Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01480206 · ClinicalTrials.gov registry record
Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 58
- Enrollment target
NCT01480206: Completed study, sponsored by Philips Clinical & Medical Affairs Global.
NCT01480206 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01480206 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
As endovascular procedures become more complex, there is a growing need for 3D image overlay to assist with device guidance and placement. Currently, a 3D image is typically created intra-operatively using 3D rotational angiography (3D-RA) or cone-beam CT (XperCT). This 3D image may then be overlaid on live fluoroscopy to provide 3D guidance information (Dynamic 3D Roadmapping). Philips Healthcare multimodality overlay products allows registration of a pre-acquired MR/CT or 3D rotational image to live fluoroscopy.
Primary Outcome
PI answers questions to help improve the usability of the VesselNavigator
Interventions
- OTHER Endovascular Aortic Repair (EVAR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2011-09-13 |
| Est. Completion | 2021-08-01 |
What the finished NCT01480206 record still lists
NCT01480206 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Endovascular Aortic Repair (EVAR) is the first listed.
NCT01480206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01480206 about?
NCT01480206 is a clinical study titled "Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR". As endovascular procedures become more complex, there is a growing need for 3D image overlay to assist with device guidance and placement. Currently, a 3D image is typically created intra-operatively using 3D rotational angiography (3D-RA) or cone-beam CT (XperCT). This 3D image may then be overlaid...
What is the current status of trial NCT01480206?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2011-09-13. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT01480206?
The interventions under investigation include: Endovascular Aortic Repair (EVAR) (OTHER).
Who is sponsoring clinical trial NCT01480206?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI